Compounds > 2-(4-(2-carboxyethyl)phenethylamino)-5--n-ethylcarboxamidoadenosine

2-(4-(2-carboxyethyl)phenethylamino)-5--n-ethylcarboxamidoadenosine and Carcinoma--Squamous-Cell

2-(4-(2-carboxyethyl)phenethylamino)-5--n-ethylcarboxamidoadenosine has been researched along with Carcinoma--Squamous-Cell* in 1 studies

Other Studies

1 other study(ies) available for 2-(4-(2-carboxyethyl)phenethylamino)-5--n-ethylcarboxamidoadenosine and Carcinoma--Squamous-Cell

Article	Year
A defect in KCa3.1 channel activity limits the ability of CD8 Science signaling, 2018, 04-24, Volume: 11, Issue:527 The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A Topics: Adenosine; Adenosine A2 Receptor Agonists; Adult; Aged; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Female; Gene Expression; Head and Neck Neoplasms; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Middle Aged; Phenethylamines; Receptor, Adenosine A2A; Tumor Microenvironment	2018

Article

Year

A defect in KCa3.1 channel activity limits the ability of CD8

Science signaling, 2018, 04-24, Volume: 11, Issue:527

The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A

Topics: Adenosine; Adenosine A2 Receptor Agonists; Adult; Aged; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Female; Gene Expression; Head and Neck Neoplasms; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Middle Aged; Phenethylamines; Receptor, Adenosine A2A; Tumor Microenvironment

2018